| Primary |
| Nuclear Magnetic Resonance Imaging |
51.7% |
| Nuclear Magnetic Resonance Imaging Brain |
9.6% |
| Angiogram |
9.6% |
| Drug Use For Unknown Indication |
7.8% |
| Product Used For Unknown Indication |
4.0% |
| Imaging Procedure |
3.8% |
| Nuclear Magnetic Resonance Imaging Abdominal |
3.0% |
| Pain |
1.9% |
| Hypertension |
1.6% |
| Arthrogram |
0.9% |
| Diabetes Mellitus |
0.8% |
| Fistulogram |
0.8% |
| Venogram |
0.8% |
| Diagnostic Procedure |
0.8% |
| Anaemia |
0.7% |
| X-ray Limb |
0.5% |
| Dialysis |
0.5% |
| Scan With Contrast |
0.4% |
| Arteriogram Coronary |
0.4% |
| Prophylaxis Against Transplant Rejection |
0.4% |
|
| Urticaria |
18.9% |
| Vomiting |
13.8% |
| Pain |
9.4% |
| Skin Tightness |
8.8% |
| Nephrogenic Systemic Fibrosis |
7.2% |
| Skin Fibrosis |
5.9% |
| Nausea |
5.3% |
| Scar |
4.5% |
| Pruritus |
3.6% |
| Nephrogenic Fibrosing Dermopathy |
3.1% |
| Skin Induration |
3.1% |
| Rash |
2.4% |
| Sneezing |
2.4% |
| Throat Irritation |
2.2% |
| Dyspnoea |
1.7% |
| Skin Ulcer |
1.6% |
| Throat Tightness |
1.6% |
| Skin Hypertrophy |
1.5% |
| No Adverse Event |
1.4% |
| Pain In Extremity |
1.4% |
|
| Secondary |
| Nuclear Magnetic Resonance Imaging |
43.5% |
| Angiogram |
14.7% |
| Nuclear Magnetic Resonance Imaging Brain |
10.8% |
| Nuclear Magnetic Resonance Imaging Abdominal |
3.8% |
| Pain |
3.5% |
| Hypertension |
2.6% |
| Imaging Procedure |
2.4% |
| Neoplasm |
2.2% |
| Neoplasm Malignant |
2.1% |
| Product Used For Unknown Indication |
1.8% |
| Anxiety |
1.5% |
| Fistulogram |
1.5% |
| Venogram |
1.5% |
| Diabetes Mellitus |
1.2% |
| Constipation |
1.2% |
| Anaemia |
1.2% |
| Dialysis |
1.2% |
| Drug Use For Unknown Indication |
1.2% |
| Chemotherapy |
1.1% |
| Multiple Myeloma |
0.9% |
|
| Nephrogenic Systemic Fibrosis |
25.7% |
| Skin Tightness |
15.4% |
| Skin Fibrosis |
7.7% |
| Pain |
6.8% |
| Skin Induration |
6.5% |
| Nephrogenic Fibrosing Dermopathy |
6.3% |
| Scar |
3.3% |
| Skin Hypertrophy |
3.3% |
| Renal Cell Carcinoma |
3.2% |
| Xerosis |
3.0% |
| Joint Range Of Motion Decreased |
2.4% |
| Vomiting |
2.3% |
| Skin Ulcer |
2.0% |
| Urinary Tract Infection |
1.8% |
| Pain In Extremity |
1.7% |
| Skin Ulcer Haemorrhage |
1.7% |
| Weight Decreased |
1.7% |
| Serum Ferritin Increased |
1.7% |
| Tendon Pain |
1.7% |
| Anhedonia |
1.6% |
|
| Concomitant |
| Drug Use For Unknown Indication |
14.7% |
| Hepatic Neoplasm Malignant |
10.0% |
| Prophylaxis |
9.5% |
| Osteoporosis |
8.4% |
| Nuclear Magnetic Resonance Imaging |
7.9% |
| Pain |
6.3% |
| Premedication |
5.3% |
| Anaemia |
4.7% |
| Hypercalcaemia |
4.2% |
| Antiviral Prophylaxis |
3.7% |
| Computerised Tomogram |
3.2% |
| Infection |
3.2% |
| Insomnia |
3.2% |
| Pyrexia |
3.2% |
| Vascular Imaging |
3.2% |
| Angiogram |
2.6% |
| Non-hodgkin's Lymphoma |
2.1% |
| Coronary Artery Bypass |
1.6% |
| Nerve Block |
1.6% |
| Peripheral Ischaemia |
1.6% |
|
| Nephrogenic Systemic Fibrosis |
48.1% |
| Rhabdomyolysis |
11.1% |
| Encephalopathy |
3.7% |
| Oedema |
3.7% |
| Renal Transplant |
3.7% |
| White Blood Cell Count Decreased |
3.7% |
| Abscess Limb |
1.9% |
| Back Pain |
1.9% |
| Constipation |
1.9% |
| Death |
1.9% |
| Duodenitis |
1.9% |
| General Physical Health Deterioration |
1.9% |
| No Therapeutic Response |
1.9% |
| Off Label Use |
1.9% |
| Onychomycosis |
1.9% |
| Pain |
1.9% |
| Protein Urine Present |
1.9% |
| Restlessness |
1.9% |
| Scar |
1.9% |
| Scleroderma |
1.9% |
|
| Interacting |
| Hyperzincaemia |
50.0% |
| Denture Wearer |
25.0% |
| Nuclear Magnetic Resonance Imaging |
25.0% |
|
|
